SLC7A11 and pancreatic neoplasm: Overall, multidisciplinary approaches combining molecular biology, pharmacology, and clinical research are necessary to realize the therapeutic potential of targeting SLC7A11 in pancreatic fibrosis and pancreatic cancer.